Summarize the impact of diabetes on health in relation to disease prevalence, an older adult with diabetes. Describe how diabetes impacts the health of …
MONTANA GERIATRIC EDUCATION CENTER MODULES
GERIATRIC HEALTH SCREENING CURRICULUM 2 Contact Hours Each
Overview of Geriatric Health Screening, Kim Cybulski, Pharm D
Clinical Pharmacist, St Patrick Hospital Health Sciences Center
Description: The module will discuss the basic issues that surround health
screening in the geriatric population It will:
Describe the current status of healthcare pertaining to the aging
population
Describe governmental national and state initiatives to address the
health concerns of the elderly
Define levels of disease prevention
Discuss patient-related barriers to performing geriatric health
screening
Define frequently encountered terms in health screening
Objectives:
Describe the scope of the problems facing the growing geriatric
population
Describe governmental initiatives related to the geriatric population
Distinguish between the different levels of disease prevention and
state where screening of disease fits into the preventative plan
Describe how patient-related barriers may impact geriatric screening
and recommend how to overcome
these barriers
Describe the differences between:
Accuracy precision
Specificity sensitivity
Describe how Clinical Laboratory Improvement Amendments CLIA is
important to geriatric health screening
Suggest how to handle potential emergencies that may arise during
geriatric health screening
Name key websites pertaining to geriatric health screening
Describe tests available for geriatric health screening and state when
they are appropriate for geriatric patients
Screening for Diabetes in Older Persons, Kim Cybulski, Pharm D
Description: This module will discuss the basic issues that surround
screening for diabetes in the geriatric population It will:
Describe the impact diabetes has on health
Provide an overview of diabetes: classification, causes, risk factors,
complications and prevention
Describe how diabetes can be screened for in specific populations
Describe how to use the A1c Now testing device
Briefly describe non-pharmacologic and pharmacologic therapies available
for treatment of diabetes
Objectives:
Summarize the impact of diabetes on health in relation to disease
prevalence, health
care expenditures and its relation to obesity
Describe the specialized needs of an older adult with diabetes
Describe how diabetes impacts the health of American Indians
Differentiate between type 1 and type 2 diabetes in regard to typical
age of onset, etiology, endogenous insulin secretion and insulin
resistance
Define insulin resistance and describe its role in type 2 diabetes
Identify patient risk factors for type 2 diabetes
Differentiate between macrovascular and microvascular complications
found in patients with diabetes
Describe treatment recommendations and/or goals for diabetic patients
who may have dyslipidemia or hypertension
Describe how kidney disease plays a significant role in patients with
diabetes
Describe the progressive changes found in non-proliferative and
proliferative diabetic retinopathies
Briefly discuss the three main types of neuropathies seen in patients
with diabetes
Identify patients who are good candidates for diabetes screening
Describe how to perform hemoglobin A1c test using the A1cNow device,
and identify which screened patients should be referred
Briefly describe non-pharmacologic and
pharmacologic therapies available
for treatment of diabetic patients
Screening for Lipid Disorders in Older Persons, Kim Cybulski, Pharm D
Description: A 2-hour module will discuss the basic issues which surround
screening for lipid abnormalities in the geriatric population
Objectives:
Summarize the role lipids play in atherosclerosis
Differentiate among the different lipoproteins and identify their role
in lipid transport
Summarize the pathophysiology of atherosclerosis
Discriminate between primary and secondary causes for dyslipidemias
Examine the ATP III 2001 guidelines and integrate the August 2004
revisions to the guidelines
Identify patient specific risk factors
Calculate a patients 10-year risk of developing coronary heart
disease
Given a patients 10-year risk, categorize his or her LDL goals and
cut-points for interventional therapy
Summarize components of Therapeutic Lifestyle Changes and provide
examples of acceptable modifications
Describe which patient populations are recommended for lipid
screening
Describe how the Cholestech LDX detects lipid levels and demonstrate
how to set up, perform quality assurance checks, and run a blood
sample for analysis
Describe the technique of finger-prick blood sample collection and
provide suggestions on how to improve the collection process in
difficult patients
Formulate a plan for a patient based on risk factors, therapeutic
options and determine when it is appropriate to refer a patient to his
or her primary care provider
Screening for Osteoporosis in Older Persons, Kim Cybulski, Pharm D
Description: This 2-hour module will discuss the impact of osteoporosis in
the elderly population, discuss screening technology available for
osteoporosis, and provide non-pharmacological interventions for
osteoporosisescription:
Objectives:
Describe the impact osteoporosis has on elderly patients the health
care system
List the definitions for osteoporosis
Describe bone development and pathologic changes
Identify risk factors for osteoporosis
Identify patients who should be screened for osteoporosis
Understand the technology behind quantitative ultrasound and how
fracture risk is determined
Demonstrate how to set up, calibrate, and
operate the CUBAClinical
system
Formulate a plan for a patient based on risk factors and their T- and
Z-score results
Define the daily recommendations for calcium and Vitamin D
Recommend a calcium supplement and state the rationale for choosing
one product over another
Identify ways to decrease a patients risk of falling
Screening for Thyroid Disorders in Older Persons, Kim Cybulski, Pharm D
Description: This 2-hour module will:
Describe the issues surrounding hypothyroid screening in the geriatric
population
Provide an overview of thyroid function and the impact of
hypothyroidism on body systems
Describe how to use the ThyroTest device to screen for hypothyroid
disease
Objectives:
Briefly describe the differences between hypothyroidism and subclinical
hypothyroidism
Articulate how age and sex affect the prevalence of hypothyroidism
State the main issues surrounding thyroid screening in terms of who
should be screened
Briefly summarize the synthesis of thyroid hormones
Describe the affects of thyroid hormone on target organs and metabolism
protein, lipids and carbohydrates
Articulate how low
thyroid levels may contribute to elevated lipid
levels
Describe how thyroid hormone synthesis is regulated by the brain
List common causes of hypothyroidism
Identify patients who may be good screening candidates for
hypothyroidism
Describe how to perform the thyroid screening using the ThyroTest
device, including interpretation of results and when a patient should be
referred for follow-up care
Source:invent.org
